Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
Line 69: | Line 69: | ||
| [[Media:QIBA MSK BC Public Comment Resolutions.pdf| Public Comment Resolutions]] | | [[Media:QIBA MSK BC Public Comment Resolutions.pdf| Public Comment Resolutions]] | ||
|- | |- | ||
− | | [[Media:QIBA DCE- | + | | [[Media:QIBA DCE-Profile - v2.0 - Consensus Document.pdf|MR DCE-MRI Quantification (DCEMRI-Q) 2023-12-06]] |
− | | | + | | Consensus |
− | | | + | | 2023.12-06 |
− | | | + | | [[Media:QIBA DCE-MRI Public Comment Resolutions.pdf| Public Comment Resolutions]] |
|- | |- | ||
| [[Media:MRE-QIBAProfile-2022-02-14-TECHNICALLY-CONFIRMED.pdf| MR Elastography of the Liver 2022-02-14]] | | [[Media:MRE-QIBAProfile-2022-02-14-TECHNICALLY-CONFIRMED.pdf| MR Elastography of the Liver 2022-02-14]] |
Latest revision as of 14:53, 21 December 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.